Roberto José Carvalho da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roberto José Carvalho da Silva has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Katia Cristina Bassichetto
Universidade de São Paulo, Brazil
6 shared publications - Maria Amélia de Sousa Mascena Veras
Faculdade de Ciências Medicas da Santa Casa de Sao Paulo
6 shared publications - Daniel Jason McCartney
London School of Hygiene & Tropical Medicine, United Kingdom
5 shared publications - Inês Dourado
Universidade Federal da Bahia. Instituto de Saúde Coletiva. Salvador, BA, Brasil
5 shared publications - Laio Magno
Institute of Collective Health, Federal University of Bahia (UFBA), Salvador, Brazil
5 shared publications - Maria Luiza Bazzo
UFSC
5 shared publications
Latest Publications
- 15 February 2024
- Published by BMJ in Sexually Transmitted Infections
- Vol. 100 (3) , 133-137
Aetiological molecular identification of sexually transmitted infections that cause urethral discharge syndrome and genital ulcer disease in Brazilian men: a nationwide study
Background: Little is known about the aetiology of urethral discharge syndrome (UDS) and genital ulcer disease (GUD) in Brazil due to limited access to laboratory tests and treatment based mainly on the syndromic approach.Objectives: To update Brazilian treatment guidelines according to the current scenario, the first nationwide aetiological study for UDS and GUD was performed.Methods: Male participants with urethral discharge (UD) and/or genital ulcer (GU) reports were enrolled. Sample collection was performed by 12 sentinel sites located in the five Brazilian regions. Between 2018 and 2020, 1141 UD and 208 GU samples were collected in a Universal Transport Medium-RT (Copan). A multiplex quantitative PCR kit (Seegene) was used to detect UD:Chlamydia trachomatis(CT),Mycoplasma genitalium(MG),M. hominis(MH),Neisseria gonorrhoeae(NG),Trichomonas vaginalis(TV),Ureaplasma parvum(UP),U. urealyticum(UU) and another kit to detect GU: cytomegalovirus (CMV),Haemophilus ducreyi(HD), herpes simplex virus type 1 (HSV1), herpes simplex virus type 2 (HSV2), lymphogranuloma venereum (LGV),Treponema pallidum(TP) and varicella-zoster virus (VZV).Results: In UD samples, the frequency of pathogen detection was NG: 78.38%, CT: 25.6%, MG: 8.3%, UU: 10.4%, UP: 3.5%, MH: 3.5% and TV: 0.9%. Coinfection was assessed in 30.9% of samples, with 14.3% of NG/CT coinfection. The most frequent pathogen identified in GU was HSV2, present in 40.8% of the samples, followed by TP at 24.8%, LGV and CMV at 1%, and HSV1 at 0.4%. Coinfection of TP/HSV2 was detected in 4.4% of samples. VZV and HD were not detected. In 27.7% of the GU samples, no pathogen was detected.Conclusion: This study provided the acquisition of unprecedented data on the aetiology of UDS and GUD in Brazil, demonstrated the presence of a variety of pathogens in both sample types and reaffirmed the aetiologies known to be most prevalent globally.
- 15 February 2024
- Published by BMJ in Sexually Transmitted Infections
- Vol. 100 (3) , 133-137
Aetiological molecular identification of sexually transmitted infections that cause urethral discharge syndrome and genital ulcer disease in Brazilian men: a nationwide study
Background: Little is known about the aetiology of urethral discharge syndrome (UDS) and genital ulcer disease (GUD) in Brazil due to limited access to laboratory tests and treatment based mainly on the syndromic approach.Objectives: To update Brazilian treatment guidelines according to the current scenario, the first nationwide aetiological study for UDS and GUD was performed.Methods: Male participants with urethral discharge (UD) and/or genital ulcer (GU) reports were enrolled. Sample collection was performed by 12 sentinel sites located in the five Brazilian regions. Between 2018 and 2020, 1141 UD and 208 GU samples were collected in a Universal Transport Medium-RT (Copan). A multiplex quantitative PCR kit (Seegene) was used to detect UD:Chlamydia trachomatis(CT),Mycoplasma genitalium(MG),M. hominis(MH),Neisseria gonorrhoeae(NG),Trichomonas vaginalis(TV),Ureaplasma parvum(UP),U. urealyticum(UU) and another kit to detect GU: cytomegalovirus (CMV),Haemophilus ducreyi(HD), herpes simplex virus type 1 (HSV1), herpes simplex virus type 2 (HSV2), lymphogranuloma venereum (LGV),Treponema pallidum(TP) and varicella-zoster virus (VZV).Results: In UD samples, the frequency of pathogen detection was NG: 78.38%, CT: 25.6%, MG: 8.3%, UU: 10.4%, UP: 3.5%, MH: 3.5% and TV: 0.9%. Coinfection was assessed in 30.9% of samples, with 14.3% of NG/CT coinfection. The most frequent pathogen identified in GU was HSV2, present in 40.8% of the samples, followed by TP at 24.8%, LGV and CMV at 1%, and HSV1 at 0.4%. Coinfection of TP/HSV2 was detected in 4.4% of samples. VZV and HD were not detected. In 27.7% of the GU samples, no pathogen was detected.Conclusion: This study provided the acquisition of unprecedented data on the aetiology of UDS and GUD in Brazil, demonstrated the presence of a variety of pathogens in both sample types and reaffirmed the aetiologies known to be most prevalent globally.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 27 (suppl 1)
Prevalência das hepatites A, B e C entre mulheres trans e travestis em cinco capitais brasileiras entre 2019-2021
RESUMO Objetivo: Estimar as prevalências e fatores associados com as hepatites A, B e C em mulheres trans e travestis em cinco regiões do Brasil. Métodos: Estudo transversal com mulheres trans e travestis em cinco capitais brasileiras (Campo Grande, Manaus, Porto Alegre, Salvador e São Paulo), entre dezembro/2019 e julho/2021. As amostras foram submetidas à detecção de marcadores das infecções pelos vírus das hepatites A (HAV), B (HBV) e C (HCV), utilizando-se testes rápidos e quimioluminescência. Amostras positivas foram submetidas à detecção de HBV-DNA e HCV-RNA por PCR em tempo real e genotipadas por sequenciamento de Sanger. Resultados: As análises de 1.317 amostras indicaram taxas de prevalências nas mulheres trans e travestis recrutadas de 69,1%, 24,4% e 1,5% para exposição ao HAV, HBV e HCV, respectivamente. Elevada taxa de suscetibilidade ao HBV (35,7%) e baixa prevalência do marcador vacinal (40,0%) foram observadas. Mostraram-se associadas à presença de anti-HAV: idade maior que 26 anos, autodeclarar-se preta-parda, ter apenas educação básica, história de encarceramento e uso de preservativo na última relação sexual com parceiro casual. Quanto à exposição ao HBV, foi associada a idade maior que 26 anos, cor da pele preto-parda, ter sido profissional do sexo e história de encarceramento. Idade maior de 37 anos, história de abuso sexual e consumo frequente de álcool foram associadas ao HCV. Conclusão: As maiores prevalências de HAV nessa população encontram-se nas regiões Norte e Nordeste. Com relação ao HBV, a prevalência encontrada foi superior à encontrada na população geral, sugerindo maior vulnerabilidade. A prevalência do HCV foi semelhante à encontrada na população geral.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 27 (suppl 1)
Open AccessPrevalência das hepatites A, B e C entre mulheres trans e travestis em cinco capitais brasileiras entre 2019-2021
RESUMO Objetivo: Estimar as prevalências e fatores associados com as hepatites A, B e C em mulheres trans e travestis em cinco regiões do Brasil. Métodos: Estudo transversal com mulheres trans e travestis em cinco capitais brasileiras (Campo Grande, Manaus, Porto Alegre, Salvador e São Paulo), entre dezembro/2019 e julho/2021. As amostras foram submetidas à detecção de marcadores das infecções pelos vírus das hepatites A (HAV), B (HBV) e C (HCV), utilizando-se testes rápidos e quimioluminescência. Amostras positivas foram submetidas à detecção de HBV-DNA e HCV-RNA por PCR em tempo real e genotipadas por sequenciamento de Sanger. Resultados: As análises de 1.317 amostras indicaram taxas de prevalências nas mulheres trans e travestis recrutadas de 69,1%, 24,4% e 1,5% para exposição ao HAV, HBV e HCV, respectivamente. Elevada taxa de suscetibilidade ao HBV (35,7%) e baixa prevalência do marcador vacinal (40,0%) foram observadas. Mostraram-se associadas à presença de anti-HAV: idade maior que 26 anos, autodeclarar-se preta-parda, ter apenas educação básica, história de encarceramento e uso de preservativo na última relação sexual com parceiro casual. Quanto à exposição ao HBV, foi associada a idade maior que 26 anos, cor da pele preto-parda, ter sido profissional do sexo e história de encarceramento. Idade maior de 37 anos, história de abuso sexual e consumo frequente de álcool foram associadas ao HCV. Conclusão: As maiores prevalências de HAV nessa população encontram-se nas regiões Norte e Nordeste. Com relação ao HBV, a prevalência encontrada foi superior à encontrada na população geral, sugerindo maior vulnerabilidade. A prevalência do HCV foi semelhante à encontrada na população geral.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 27 (suppl 1)
Prevalências de clamídia e gonorreia entre mulheres trans e travestis de cinco capitais brasileiras, 2019–2021
Estimar as prevalências e os fatores associados à detecção de Chlamydia trachomatis (CT) e Neisseria gonorrhoeae (NG) em mulheres trans e travestis em cinco capitais brasileiras.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 27 (suppl 1)
Open AccessPrevalências de clamídia e gonorreia entre mulheres trans e travestis de cinco capitais brasileiras, 2019–2021
Estimar as prevalências e os fatores associados à detecção de Chlamydia trachomatis (CT) e Neisseria gonorrhoeae (NG) em mulheres trans e travestis em cinco capitais brasileiras.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 27 (suppl 1)
Prevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019–2021
To estimate the prevalence and factors associated with the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in transgender women and travestis in five Brazilian capitals.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 27 (suppl 1)
Open AccessPrevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019–2021
To estimate the prevalence and factors associated with the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in transgender women and travestis in five Brazilian capitals.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 27 (suppl 1)
Hepatitis A, B and C prevalence among transgender women and travestis in five Brazilian capitals between 2019-2021
To estimate the prevalence and factors associated with hepatitis A, B, and C in transgender women and travestis's networks, in 5 regions of Brazil.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 27 (suppl 1)
Open AccessHepatitis A, B and C prevalence among transgender women and travestis in five Brazilian capitals between 2019-2021
To estimate the prevalence and factors associated with hepatitis A, B, and C in transgender women and travestis's networks, in 5 regions of Brazil.
- 30 November 2023
- Published by BMJ in Sexually Transmitted Infections
- Vol. 100 (1) , 3-9
Anorectal gonorrhoea and chlamydia among transgender women in Brazil: prevalence and assessment of performance and cost of anorectal infection detection and management approaches
Objectives: We aimed to determine the prevalence of anorectalNeisseria gonorrhoeae(NG) andChlamydia trachomatis(CT) among transgender women in Brazil, and to assess the performance and costs of various approaches for the diagnosis and management of anorectal NG/CT.Methods: TransOdara was a multicentric, cross-sectional STI prevalence study among 1317 transgender women conducted in five capital cities representing all Brazilian regions. Participants aged>18 years were recruited using respondent-driven sampling (RDS), completed an interviewer-led questionnaire, offered an optional physical examination and given choice between self-collected or provider-collected samples for NG/CT testing. Performance and cost indicators of predetermined management algorithms based on the WHO recommendations for anorectal symptoms were calculated.Results: Screening uptake was high (94.3%) and the estimated prevalence of anorectal NG, CT and NG and/or CT was 9.1%, 8.9% and 15.2%, respectively. Most detected anorectal NG/CT infections were asymptomatic (NG: 87.6%, CT: 88.9%), with a limited number of participants reporting any anorectal symptoms (9.1%). Of those who permitted anal examination, few had clinical signs of infection (13.6%). Sensitivity of the tested algorithms ranged from 1.4% to 5.1% (highest for treatment based on the reported anorectal discharge or ulcer and receptive anal intercourse (RAI) in the past 6 months) and specificity from 98.0% to 99.3% (highest for treatment based on the reported anorectal discharge with clinical confirmation or report of RAI). The estimated cost-per-true case of anorectal NG/CT infection treated varied from lowest providing treatment for anorectal discharge syndrome based on the reported RAI ($2.70–4.28), with algorithms including clinical examinations decreasing cost-effectiveness.Conclusions: High prevalence of mostly asymptomatic anorectal NG and CT was observed among Brazilian transgender women. Multi-site NG/CT screening should be offered to transgender women. Where diagnostic testing capacity is limited, syndromic management for those presenting with anorectal symptoms is recommended.
- 30 November 2023
- Published by BMJ in Sexually Transmitted Infections
- Vol. 100 (1) , 3-9
Anorectal gonorrhoea and chlamydia among transgender women in Brazil: prevalence and assessment of performance and cost of anorectal infection detection and management approaches
Objectives: We aimed to determine the prevalence of anorectalNeisseria gonorrhoeae(NG) andChlamydia trachomatis(CT) among transgender women in Brazil, and to assess the performance and costs of various approaches for the diagnosis and management of anorectal NG/CT.Methods: TransOdara was a multicentric, cross-sectional STI prevalence study among 1317 transgender women conducted in five capital cities representing all Brazilian regions. Participants aged>18 years were recruited using respondent-driven sampling (RDS), completed an interviewer-led questionnaire, offered an optional physical examination and given choice between self-collected or provider-collected samples for NG/CT testing. Performance and cost indicators of predetermined management algorithms based on the WHO recommendations for anorectal symptoms were calculated.Results: Screening uptake was high (94.3%) and the estimated prevalence of anorectal NG, CT and NG and/or CT was 9.1%, 8.9% and 15.2%, respectively. Most detected anorectal NG/CT infections were asymptomatic (NG: 87.6%, CT: 88.9%), with a limited number of participants reporting any anorectal symptoms (9.1%). Of those who permitted anal examination, few had clinical signs of infection (13.6%). Sensitivity of the tested algorithms ranged from 1.4% to 5.1% (highest for treatment based on the reported anorectal discharge or ulcer and receptive anal intercourse (RAI) in the past 6 months) and specificity from 98.0% to 99.3% (highest for treatment based on the reported anorectal discharge with clinical confirmation or report of RAI). The estimated cost-per-true case of anorectal NG/CT infection treated varied from lowest providing treatment for anorectal discharge syndrome based on the reported RAI ($2.70–4.28), with algorithms including clinical examinations decreasing cost-effectiveness.Conclusions: High prevalence of mostly asymptomatic anorectal NG and CT was observed among Brazilian transgender women. Multi-site NG/CT screening should be offered to transgender women. Where diagnostic testing capacity is limited, syndromic management for those presenting with anorectal symptoms is recommended.
- Open Access
- 27 November 2023
- Published by Elsevier in IJID Regions
- Vol. 10, 114-122
Clinical and epidemiological features of mpox in a Brazilian reference center for HIV and sexually transmitted infections: A cross-sectional study
- 27 November 2023
- Published by Elsevier in IJID Regions
- Vol. 10, 114-122
Open AccessClinical and epidemiological features of mpox in a Brazilian reference center for HIV and sexually transmitted infections: A cross-sectional study
- Open Access
- 30 May 2023
- Published by Coordenadoria de Controle de Doencas da Secretaria de Estado da Saude de Sao Paulo in BEPA. Boletim Epidemiológico Paulista
- Vol. 20, 1-20
Diagnóstico laboratorial da infecção pelo HIV em travestis e mulheres transexuais no Brasil, 2019-2021
A prevalência de HIV em travestis e mulheres transexuais (TrMT) é desproporcionalmente maior quando comparada com a população geral do Brasil. O objetivo deste estudo foi analisar – por meio de ensaios molecular e sorológicos convencionais para o diagnóstico da infecção pelo HIV – amostras de sangue de uma população TrMT de cinco capitais brasileiras que haviam apresentado resultado reagente em testes rápidos (TR). Um total de 435 amostras com resultado reagente em pelo menos um TR foi encaminhado ao laboratório de referência do estado de São Paulo – o Instituto Adolfo Lutz (IAL) –, para que elas fossem analisadas por meio de testes laboratoriais convencionais. Das amostras avaliadas, 99,3% (432/435) foram reagentes para HIV nos testes laboratoriais convencionais, sendo que, destas, 22,7% (98/432) apresentaram carga viral HIV-1 acima de 5.000 cópias/ml e 77,3% (334/432) mostraram-se reagentes em testes sorológicos (imunoensaio de quimioluminescência, ou ELISA, e imunoblot rápido). As três amostras restantes (0,7%) foram classificadas como “indeterminada para HIV”, com base em ensaios molecular e sorológicos convencionais. A sensibilidade analítica dos diferentes ensaios – molecular e sorológicos – utilizados neste estudo pode ter variado pela influência da imunossupressão viral do HIV-1 resultante da terapia antirretroviral (TARV). Estudos complementares são necessários para melhor entender o impacto da terapia no diagnóstico do HIV.
- 30 May 2023
- Published by Coordenadoria de Controle de Doencas da Secretaria de Estado da Saude de Sao Paulo in BEPA. Boletim Epidemiológico Paulista
- Vol. 20, 1-20
Open AccessDiagnóstico laboratorial da infecção pelo HIV em travestis e mulheres transexuais no Brasil, 2019-2021
A prevalência de HIV em travestis e mulheres transexuais (TrMT) é desproporcionalmente maior quando comparada com a população geral do Brasil. O objetivo deste estudo foi analisar – por meio de ensaios molecular e sorológicos convencionais para o diagnóstico da infecção pelo HIV – amostras de sangue de uma população TrMT de cinco capitais brasileiras que haviam apresentado resultado reagente em testes rápidos (TR). Um total de 435 amostras com resultado reagente em pelo menos um TR foi encaminhado ao laboratório de referência do estado de São Paulo – o Instituto Adolfo Lutz (IAL) –, para que elas fossem analisadas por meio de testes laboratoriais convencionais. Das amostras avaliadas, 99,3% (432/435) foram reagentes para HIV nos testes laboratoriais convencionais, sendo que, destas, 22,7% (98/432) apresentaram carga viral HIV-1 acima de 5.000 cópias/ml e 77,3% (334/432) mostraram-se reagentes em testes sorológicos (imunoensaio de quimioluminescência, ou ELISA, e imunoblot rápido). As três amostras restantes (0,7%) foram classificadas como “indeterminada para HIV”, com base em ensaios molecular e sorológicos convencionais. A sensibilidade analítica dos diferentes ensaios – molecular e sorológicos – utilizados neste estudo pode ter variado pela influência da imunossupressão viral do HIV-1 resultante da terapia antirretroviral (TARV). Estudos complementares são necessários para melhor entender o impacto da terapia no diagnóstico do HIV.
- Open Access
- 21 July 2022
- Published by Associacao Brasileira de Psiquiatria in Debates em Psiquiatria
- Vol. 12, 1-4
Capacitação em psicoterapia em um programa de residência médica em rede em psiquiatria
No Brasil o treinamento em psicoterapia nos programas de residência médica em psiquiatria é obrigatório mas não existe um consenso sobre como ele que deve ser realizado. O formato do programa de residência médica em rede em psiquiatria da Secretaria Municipal de Saúde de São Paulo prevê um curso teórico semanal de conceitos básicos de psicologia e psicoterapia no primeiro ano e atendimentos em psicoterapia durante o segundo e terceiro ano nas diversas Unidades Básicas de Saúde do programa. As supervisões dos atendimentos são realizadas em grupo uma vez por semana em período de 4 horas por equipe de psicólogos.
- 21 July 2022
- Published by Associacao Brasileira de Psiquiatria in Debates em Psiquiatria
- Vol. 12, 1-4
Open AccessCapacitação em psicoterapia em um programa de residência médica em rede em psiquiatria
No Brasil o treinamento em psicoterapia nos programas de residência médica em psiquiatria é obrigatório mas não existe um consenso sobre como ele que deve ser realizado. O formato do programa de residência médica em rede em psiquiatria da Secretaria Municipal de Saúde de São Paulo prevê um curso teórico semanal de conceitos básicos de psicologia e psicoterapia no primeiro ano e atendimentos em psicoterapia durante o segundo e terceiro ano nas diversas Unidades Básicas de Saúde do programa. As supervisões dos atendimentos são realizadas em grupo uma vez por semana em período de 4 horas por equipe de psicólogos.
- Open Access
- 1 January 2022
- Published by Zeppelini Editorial e Comunicacao in Jornal Brasileiro de Doenças Sexualmente Transmissíveis
- Vol. 34
Severe monkeypox case associated with recent laboratory diagnosis of HIV: case report
Introduction: Monkeypox is a zoonosis caused by the monkeypox virus. The first confirmed human case was in 1970, when the virus was isolated from a child in the Democratic Republic of the Congo. Since the beginning of May 2022, a large and unexpected outbreak has been documented globally, with the first cases initially described in the UK reaching around 70 countries today. The causes of this explosive increase in patients are not well understood, but exceed more than ten thousand10,000 infected by the third week of July 2022. Clinical and epidemiological presentations have been distinct from endemic cases and from small outbreaks previously described in non- endemic areas. Objective: The aim of this study was to describe the evolutionary and epidemiological, clinical characteristics of Monkeypox and human immunodeficiency virus co-infection in a patient treated at an STI/AIDS Reference Service in São Paulo, Brazil. Methods: information contained in this study was obtained through a review of the medical records, interviews with the patient, photographic record of the diagnostic methods, to which the patient was submitted and review of the literature. Results: A Brazilian man, with no epidemiological history of travel who was diagnosed with Monkeypox virus through polymerase chain reaction. At the same time of this diagnosis, he received a laboratory diagnosis of human immunodeficiency virus, Chlamydia Urethritis, and Late Latent Syphilis. Conclusion: To reduce the risk of the dissemination of Monkeypox, strategies at the public health level are necessary, with the dissemination of information and the development of prevention projects with targeted information and recommendations for vulnerable populations, especially men who have sex with men, with great prudence, seeking not to favor the development of stigmas as already experienced at the beginning of the human immunodeficiency virus epidemic.
- 1 January 2022
- Published by Zeppelini Editorial e Comunicacao in Jornal Brasileiro de Doenças Sexualmente Transmissíveis
- Vol. 34
Open AccessSevere monkeypox case associated with recent laboratory diagnosis of HIV: case report
Introduction: Monkeypox is a zoonosis caused by the monkeypox virus. The first confirmed human case was in 1970, when the virus was isolated from a child in the Democratic Republic of the Congo. Since the beginning of May 2022, a large and unexpected outbreak has been documented globally, with the first cases initially described in the UK reaching around 70 countries today. The causes of this explosive increase in patients are not well understood, but exceed more than ten thousand10,000 infected by the third week of July 2022. Clinical and epidemiological presentations have been distinct from endemic cases and from small outbreaks previously described in non- endemic areas. Objective: The aim of this study was to describe the evolutionary and epidemiological, clinical characteristics of Monkeypox and human immunodeficiency virus co-infection in a patient treated at an STI/AIDS Reference Service in São Paulo, Brazil. Methods: information contained in this study was obtained through a review of the medical records, interviews with the patient, photographic record of the diagnostic methods, to which the patient was submitted and review of the literature. Results: A Brazilian man, with no epidemiological history of travel who was diagnosed with Monkeypox virus through polymerase chain reaction. At the same time of this diagnosis, he received a laboratory diagnosis of human immunodeficiency virus, Chlamydia Urethritis, and Late Latent Syphilis. Conclusion: To reduce the risk of the dissemination of Monkeypox, strategies at the public health level are necessary, with the dissemination of information and the development of prevention projects with targeted information and recommendations for vulnerable populations, especially men who have sex with men, with great prudence, seeking not to favor the development of stigmas as already experienced at the beginning of the human immunodeficiency virus epidemic.